Krzysztof Palczewski Selected Research

Ligands

10/2018	Protective Effect of a Locked Retinal Chromophore Analog against Light-Induced Retinal Degeneration.
5/2013	Photoreceptor proteins initiate microglial activation via Toll-like receptor 4 in retinal degeneration mediated by all-trans-retinal.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Krzysztof Palczewski Research Topics

Disease

41	Retinal Degeneration 10/2022 - 11/2002
21	Macular Degeneration (Age-Related Maculopathy) 04/2024 - 10/2009
21	Retinal Diseases 04/2023 - 09/2008
20	Retinitis Pigmentosa (Pigmentary Retinopathy) 04/2024 - 04/2003
20	Blindness (Hysterical Blindness) 01/2024 - 05/2002
13	Stargardt Disease 12/2023 - 08/2011
11	Leber Congenital Amaurosis 10/2022 - 04/2004
6	Inflammation (Inflammations) 05/2024 - 04/2011
6	Photophobia (Light Sensitivity) 01/2023 - 05/2002
6	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2021 - 10/2013
6	Retinal Dystrophies 01/2021 - 04/2012
6	Neoplasms (Cancer) 01/2021 - 08/2002
4	Inborn Genetic Diseases (Disease, Hereditary) 01/2023 - 01/2018
4	Vision Disorders (Hemeralopia) 01/2021 - 04/2004
4	Cone-Rod Dystrophies 04/2011 - 07/2007
3	Phototoxic Dermatitis (Phototoxicity) 04/2024 - 07/2015
3	Night Blindness (Nyctalopia) 01/2022 - 10/2018
3	Proteostasis Deficiencies 01/2022 - 01/2017
3	Vitamin A Deficiency 10/2014 - 07/2012
2	Frontotemporal Dementia (Semantic Dementia) 12/2023 - 01/2022
2	Disease Progression 12/2023 - 01/2020
2	Atrophy 01/2022 - 09/2008
2	Eye Diseases (Eye Disease) 01/2020 - 06/2017
2	Geographic Atrophy 01/2017 - 08/2014
2	Usher Syndromes (Usher Syndrome) 01/2016 - 07/2009
2	Choroidal Neovascularization 10/2009 - 09/2008
2	Fundus Albipunctatus 10/2006 - 11/2002
1	Bardet-Biedl Syndrome (Syndrome, Bardet-Biedl) 04/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2023
1	Toxic Optic Neuropathy 01/2022
1	Osteitis Deformans (Paget's Disease of Bone) 01/2022
1	Muscular Diseases (Myopathy) 01/2022
1	Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia 01/2021
1	Thrombosis (Thrombus) 11/2020
1	Gliosis 01/2020
1	Ganglion Cysts (Ganglion) 01/2020

Drug/Important Bio-Agent (IBA)

56	Retinaldehyde (Retinal)IBA 05/2024 - 05/2002
26	Proteins (Proteins, Gene)FDA Link 04/2024 - 04/2003
23	RetinoidsIBA 10/2022 - 11/2002
16	OpsinsIBA 01/2023 - 11/2002
11	Rhodopsin (Visual Purple)IBA 01/2023 - 05/2002
9	Vitamin A (Retinol)FDA LinkGeneric 04/2023 - 11/2002
7	retinylamineIBA 01/2021 - 12/2007
5	Retinal Pigments (Pigments, Visual)IBA 01/2022 - 04/2008
5	9-cis-retinalIBA 09/2021 - 05/2002
5	EnzymesIBA 08/2014 - 07/2006
4	Rod OpsinsIBA 01/2018 - 01/2013
4	Retinyl EstersIBA 11/2017 - 05/2002
4	LipidsIBA 06/2017 - 06/2010
4	MicroRNAs (MicroRNA)IBA 01/2017 - 09/2011
3	Schiff Bases (Schiff Base)IBA 01/2023 - 01/2014
3	retinol acetateIBA 10/2022 - 10/2009
3	lecithin-retinol acyltransferaseIBA 01/2015 - 06/2009
3	Carotenoids (Carotene)IBA 11/2013 - 03/2011
3	retinol dehydrogenaseIBA 04/2012 - 07/2007
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 04/2012 - 01/2010
2	CeramidesIBA 04/2024 - 12/2023
2	Complement System Proteins (Complement)IBA 01/2023 - 10/2009
2	CB-5083IBA 01/2022 - 01/2021
2	Valosin Containing ProteinIBA 01/2022 - 01/2021
2	Peptides (Polypeptides)IBA 01/2021 - 08/2002
2	Adenine FDA LinkGeneric 01/2021 - 11/2020
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2021 - 12/2014
2	A2-E (N-retinylidene-N-retinylethanolamine)IBA 01/2020 - 12/2007
2	retinal dimerIBA 01/2020 - 11/2009
2	LigandsIBA 10/2018 - 05/2013
2	c-Mer Tyrosine KinaseIBA 11/2017 - 12/2016
2	DNA (Deoxyribonucleic Acid)IBA 06/2017 - 09/2008
2	AminesIBA 07/2015 - 12/2011
2	LipofuscinIBA 06/2015 - 09/2008
2	Triglycerides (Triacylglycerol)IBA 01/2015 - 07/2012
2	Membrane Proteins (Integral Membrane Proteins)IBA 04/2014 - 07/2009
2	Messenger RNA (mRNA)IBA 05/2013 - 09/2004
2	Phospholipids (Phosphatides)FDA LinkGeneric 07/2012 - 01/2012
2	TransferasesIBA 05/2010 - 07/2006
2	LecithinsIBA 05/2010 - 07/2006
2	retinoid isomerohydrolase (retinol isomerase)IBA 06/2009 - 09/2007
2	Oxidoreductases (Dehydrogenase)IBA 10/2006 - 11/2002
1	Adiponectin ReceptorsIBA 04/2024
1	DNA-Binding Proteins (DNA Binding Protein)IBA 12/2023
1	CytokinesIBA 01/2022
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2022
1	retinol dehydrogenase 5IBA 01/2022
1	Dopamine Receptors (Dopamine Receptor)IBA 11/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2021
1	Adrenergic Agents (Adrenergic Drugs)IBA 11/2021
1	Streptozocin (Streptozotocin)FDA Link 11/2021
1	Serotonin (5 Hydroxytryptamine)IBA 11/2021
1	Indicators and Reagents (Reagents)IBA 06/2021
1	Valine (L-Valine)FDA Link 01/2021
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Thrombin FDA Link 11/2020
1	protease-activated receptor 4IBA 11/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	HeterochromatinIBA 01/2020

Therapy/Procedure

24	Therapeutics 01/2023 - 06/2006
4	Injections 01/2024 - 01/2018
2	Oral Administration 12/2014 - 05/2002